Since ABCG2 function is also an important determinant of the ADME-tox properties of numerous drugs, including those (e.g. metformin, glyburide, or certain statins) used in the treatment of T2DM, this polymorphism may also affect the treatment efficacy of T2DM [26–30]. Here, ABCG2 is linked to type 2 diabetes mellitus.